Detalles de la búsqueda
1.
Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents.
Bioorg Chem
; 98: 103726, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171987
2.
Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold.
Bioorg Chem
; 87: 655-666, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952061
3.
Corrigendum to "Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives" [Bioorg. Med. Chem. 15 (2007) 2434-2440].
Bioorg Med Chem
; 25(9): 2679, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341404
4.
HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability.
J Med Chem
; 63(24): 15906-15945, 2020 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33314925
5.
4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity.
Chem Biol Drug Des
; 85(5): 608-22, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25318985
6.
Synthesis and antitubercular activity of 6-chloro (unsubstituted)- 2-methoxy-9-substituted acridine derivatives.
Arch Pharm Res
; 27(7): 713-9, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15356996
7.
Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives.
Bioorg Med Chem
; 15(6): 2434-40, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17275318
Resultados
1 -
7
de 7
1
Próxima >
>>